Menu
Back to Journals » OncoTargets and Therapy » Volume 12
Review
Second-generation EGFR and ErbB tyrosine kinase inhibitors as first-line treatments for non-small cell lung cancer
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 13,433 | Dovepress* | 11,651+ | 1,873 | 13,524 | |
| PubMed Central* | 1,782 | 671 | 2,453 | ||
| Totals | 13,433 | 2,544 | 15,977 | ||
| *Since 15 August 2019 | |||||
View citations on PubMed Central and Google Scholar